New US study links type 2 diabetes drug Glipizide to 13% higher heart risk. Experts urge caution as almost 50,000 patients analyzed nationwide.
Live from Morristown: Real-world US study confirms BEYFORTUS shields infants from RSV, cutting illness rates and hospitalizations.
